Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / American Depositary Shares, each representing 1 Ordinary Shares
-
Shares outstanding
-
100M
-
Number of holders
-
44
-
Total 13F shares, excl. options
-
6.12M
-
Shares change
-
+6.12M
-
Total reported value, excl. options
-
$212M
-
Value change
-
+$212M
-
Number of buys
-
44
-
Price
-
$34.59
Significant Holders of Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) as of Q1 2015
44 filings reported holding CLLS - Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares as of Q1 2015.
Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.12M shares
of 100M outstanding shares and own 6.1% of the company stock.
Largest 10 shareholders include FMR LLC (3.45M shares), JPMORGAN CHASE & CO (301K shares), PRICE T ROWE ASSOCIATES INC /MD/ (300K shares), ORBIMED ADVISORS LLC (300K shares), FRANKLIN RESOURCES INC (245K shares), LAZARD ASSET MANAGEMENT LLC (222K shares), BlackRock Advisors LLC (163K shares), DEERFIELD MANAGEMENT CO (151K shares), Artal Group S.A. (100K shares), and BlackRock Group LTD (96.1K shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.